Metraipolis › archive › dc_49abd11ab508

Safety and Efficacy of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Proportions from… — Europe PMC PMID:40940825

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40940825
DOI
10.3390/cancers17172727
License (as archived)
solo-consultazione
Archived
2026-11-10T10:19:48.665Z
SHA-256 of the archived text
4005a196051e84a2e3f6fca7b3eb64c863c28c9868b698a76cdb8e29f699977a
Stable URL of this page
https://metraipolis.com/documento/dc_49abd11ab508

How to cite

Safety and Efficacy of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Proportions from… — Europe PMC PMID:40940825 — Europe PMC (en), https://europepmc.org/article/MED/40940825 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_49abd11ab508 (Metraipolis archive dc_49abd11ab508, sha256 4005a196051e84a2e3f6fca7b3eb64c863c28c9868b698a76cdb8e29f699977a)
BibTeX
@misc{dc49abd11ab508,
  title = {Safety and Efficacy of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Proportions from… — Europe PMC PMID:40940825},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40940825},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_49abd11ab508; sha256 4005a196051e84a2e3f6fca7b3eb64c863c28c9868b698a76cdb8e29f699977a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40940825. Agents can read the archived copy with the MCP tool read_document.